These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24103424)

  • 1. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
    Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
    Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.
    Luo Q; Yu XQ; Smith DP; Goldsbury DE; Cooke-Yarborough C; Patel MI; O'Connell DL
    BMJ Open; 2017 Jan; 7(1):e014259. PubMed ID: 28077413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis--A population-based study in New South Wales.
    Tervonen HE; Walton R; Roder D; You H; Morrell S; Baker D; Aranda S
    Cancer Epidemiol; 2016 Feb; 40():87-94. PubMed ID: 26703888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
    Hayen A; Smith DP; Patel MI; O'Connell DL
    Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
    Nguyen VT; Amin J; Law MG; Dore GJ
    J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
    Tracey EA; Roder DM; Currow DC
    Cancer Causes Control; 2012 Feb; 23(2):255-62. PubMed ID: 22120005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
    Tracey E; Roder D; Luke C; Bishop J
    BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unstaged cancer in a population-based registry: prevalence, predictors and patient prognosis.
    Gurney J; Sarfati D; Stanley J; Dennett E; Johnson C; Koea J; Simpson A; Studd R
    Cancer Epidemiol; 2013 Aug; 37(4):498-504. PubMed ID: 23548729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in survival from prostate cancer in Denmark, Iceland and Sweden.
    Brasso K; Ingimarsdóttir IJ; Rusch E; Engholm G; Adolfsson J; Tryggvadóttir L; Jónsson E; Bill-Axelson A; Holmberg E; Storm HH
    Eur J Cancer; 2013 May; 49(8):1984-92. PubMed ID: 23453749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of progression to metastatic prostate cancer in Australia.
    Luo Q; Yu XQ; Smith DP; O'Connell DL
    Cancer Epidemiol; 2015 Aug; 39(4):617-22. PubMed ID: 25983117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
    Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
    BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.
    Jack RH; Davies EA; Møller H
    BJU Int; 2010 May; 105(9):1226-30. PubMed ID: 19878505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).
    Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer prevalence in New South Wales Australia: a population-based study.
    Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
    Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explaining the race difference in prostate cancer stage at diagnosis.
    Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of ultraviolet radiation-B (305 nm), season of diagnosis, and latitude on the survival outcome of prostate cancer in the high UV environment of Australia.
    Nair-Shalliker V; Smith DP; Egger S; Clements MS; Rahman MB; Armstrong BK
    Cancer Causes Control; 2013 Nov; 24(11):2005-11. PubMed ID: 23974842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and degree of spread for female breast cancers in New South Wales from 1980 to 2003: implications for cancer control.
    Tracey E; Roder D; Zorbas H; Villanueva E; Jelfs P; Bishop J
    Cancer Causes Control; 2008 Dec; 19(10):1121-30. PubMed ID: 18521714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.